FTC Halts Stem Cell Claims
A California-based physician and the companies that he controls have settled charges by the Federal Trade Commission that “amniotic stem cell therapy” can treat serious diseases, such as Parkinson’s disease, autism, macular degeneration, cerebral palsy, multiple sclerosis and heart attacks. As set forth in the complaint, the defendants earned millions of
Read More